NEW YORK, Jan. 30, 2015 /PRNewswire/ -- Gabrielle's Angel
Foundation announced today that global investor and philanthropist
Jho Low has joined the Foundation's
Board of Directors. Low was honored at Angel Ball 2014 – the Foundation's annual
fundraiser – in recognition of his significant humanitarian and
philanthropic contributions in support of cancer research.
"Mr. Low has proven his tremendous commitment to cancer research
through his charitable work, and we are honored to have him join
our board," said Co-founder Denise
Rich. "We look forward to working closely with him to
fulfill our mission of funding more effective therapies for
patients with leukemia, lymphoma and related cancers."
"Gabrielle's Angel Foundation is an essential organization in
the fight against cancer, a disease that has affected so many of us
and our families, including my own," said Jho Low, Chief Executive Officer of Jynwel
Capital Limited and Director of Jynwel Charitable Foundation
Limited. "Gabrielle's Angel Foundation has been a partner of Jynwel
Charitable Foundation for the last two years, and I am excited to
work even more closely with the team on an ongoing basis to help
eradicate this deadly disease."
Low is a global investor and philanthropist who encourages
market access and advances human progress through capital and
social investments across a diverse range of projects. He is the
co-founder and Chief Executive Officer for Jynwel Capital Limited,
an international investment firm based in Hong Kong. Low oversees both the operations
and investment strategy for the firm and cultivates lifelong
partnerships with significant investors in Asia and the Middle
East, such as leading sovereign wealth funds, major
international investment companies and large family
enterprises.
Low has led and invested in numerous mergers and acquisitions,
restructurings and financings, cross-border transactions, leveraged
buyouts, and other investment projects of various sizes and
complexity across a variety of sectors, including media and
entertainment, consumer and retail, energy and resources, real
estate and hospitality, precious metals, commodities, and
infrastructure.
Low is a director of Jynwel Charitable Foundation Limited ("the
Foundation"), a charitable institution committed to funding
breakthrough programs that scale and accelerate advancements in
public health, environmental & wildlife conservation, and
education in every corner of the world. The Foundation provides
substantial, long-term grants towards global efforts at cancer and
research, environmental & wildlife preservation, and education,
building on the multi-generational legacy of the Low family's
philanthropy.
Low has served on the board and as an advisor of a number of
listed, private and sovereign wealth funded companies. Low is
currently a member of the board of the Viceroy Hotel Group and The
Electrum Group, and he is also an alternate director of Lilestone
Limited ("Myla"). Additionally, Low is Non-executive Chairman,
Asia, for EMI Music Publishing,
also serving as a member of its advisory board. Through the
Foundation, he is a member of The Anderson Assembly and the Board
of Visitors of The University of Texas
MD Anderson Cancer Center, and he serves on the Board of Directors
of Panthera, the world's leading wild cat conservation
organization. Low maintains an active role with National Geographic
as a member of its International Council of Advisors and the
Advisory Board of National Geographic's Pristine Seas project.
Additionally, he has been selected as one of the founding Members
of the Board of Directors of the new IRIN, the humanitarian news
service; and is a member of The Trust, a distinguished society
recognizing philanthropic leaders who support Children's National
Health System in Washington,
DC.
In 2014, Low received the International Entrepreneur of the Year
Award from the Houston Asian Chamber of Commerce for his approach
to sustainable investing and disruptive philanthropy.
Low graduated with a Bachelor of Science in Economics from The
Wharton School of the University of
Pennsylvania.
About Gabrielle's Angel Foundation for Cancer
Research
Gabrielle's Angel Foundation funds the nation's best and
brightest scientific investigators whose research focuses on
finding less toxic treatments for patients with leukemia, lymphoma,
and related cancers. Since its inception, Gabrielle's Angel
Foundation has awarded $26 million in
grants making it one of the largest non-governmental sources of
grant support for blood cancer research in the nation. In 2012, the
Foundation opened a sister chapter, Gabrielle's Angel Foundation
UK, which provides support for blood cancer research at
Great Britain's leading
institutions. Help us on our quest: @CureCancerNow. For more
information, please visit: gabriellesangels.org.